Found: 53
Select item for more details and to access through your institution.
Intestinal Ultrasonography as an Alternative to Fecal Calprotectin to Monitor Patients with Crohn's Disease: Experience from a Novice Sonographer.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 9, p. 3402, doi. 10.1007/s10620-024-08548-w
- By:
- Publication type:
- Article
Relationships of circulating CD4<sup>+</sup> T cell subsets and cytokines with the risk of relapse in patients with Crohn's disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.864353
- By:
- Publication type:
- Article
Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 7, p. 792, doi. 10.1111/apt.17352
- By:
- Publication type:
- Article
Editorial: real‐world evidence of tofacitinib and vedolizumab in ulcerative colitis—are we one step closer to better positioning therapies after anti‐TNF failure? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 6, p. 735, doi. 10.1111/apt.17405
- By:
- Publication type:
- Article
Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 6, p. 676, doi. 10.1111/apt.17305
- By:
- Publication type:
- Article
Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1289, doi. 10.1111/apt.16377
- By:
- Publication type:
- Article
Determinants of IBD‐related disability: a cross‐sectional survey from the GETAID.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 10, p. 1098, doi. 10.1111/apt.16353
- By:
- Publication type:
- Article
Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 5, p. 577, doi. 10.1111/apt.16232
- By:
- Publication type:
- Article
Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 3, p. 400, doi. 10.1111/apt.16176
- By:
- Publication type:
- Article
Le switch de la forme intraveineuse vers la forme sous-cutanée pour l'infliximab : quand et comment switcher ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2024, v. 31, p. 7, doi. 10.1684/hpg.2024.2827
- By:
- Publication type:
- Article
Comment mieux annoncer le diagnostic d'une maladie inflammatoire chronique de l'intestin ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 6, p. 597, doi. 10.1684/hpg.2023.2597
- By:
- Publication type:
- Article
Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 5, p. 832, doi. 10.1111/jgh.15828
- By:
- Publication type:
- Article
Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn's disease.
- Published in:
- Intestinal Research, 2022, v. 20, n. 3, p. 303, doi. 10.5217/ir.2021.00018
- By:
- Publication type:
- Article
Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 12, p. 5637, doi. 10.1007/s10620-022-07474-z
- By:
- Publication type:
- Article
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 9, p. 4525, doi. 10.1007/s10620-022-07445-4
- By:
- Publication type:
- Article
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Methyl-donor supplementation prevents intestinal colonization by Adherent-Invasive E. coli in a mouse model of Crohn's disease.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69472-3
- By:
- Publication type:
- Article
Impact of screening programme to prevent anal cancer in high‐risk patients with HIV.
- Published in:
- HIV Medicine, 2024, v. 25, n. 4, p. 454, doi. 10.1111/hiv.13594
- By:
- Publication type:
- Article
Macrophages Inability to Mediate Adherent-Invasive E. coli Replication is Linked to Autophagy in Crohn's Disease Patients.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 11, p. 1394, doi. 10.3390/cells8111394
- By:
- Publication type:
- Article
Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
What score should be used for evaluation of Crohn's disease severity using magnetic resonance imaging?
- Published in:
- 2017
- By:
- Publication type:
- Letter
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.
- Published in:
- Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241265776
- By:
- Publication type:
- Article
Quelles voies d'administration pour quels patients ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, p. 23, doi. 10.1684/hpg.2021.2389
- By:
- Publication type:
- Article
Maladie cœliaque de l'adulte : peut-on se passer des biopsies duodénales pour le diagnostic ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2021, v. 28, n. 7, p. 881, doi. 10.1684/hpg.2021.2206
- By:
- Publication type:
- Article
Œsophagite à éosinophiles : enfin une formulation spécifique pour le traitement d'entretien par budésonide !
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2021, v. 28, n. 5, p. 652, doi. 10.1684/hpg.2021.2170
- By:
- Publication type:
- Article
Transplantation de microbiote fécal : une option dans le syndrome de l'intestin irritable avec ballonnements ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2021, v. 28, n. 2, p. 302, doi. 10.1684/hpg.2021.2116
- By:
- Publication type:
- Article
Cibler les sels biliaires, la clé en cas de reflux gastro-œsophagien réfractaire aux inhibiteurs de la pompe à protons ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 9, p. 949, doi. 10.1684/hpg.2020.2047
- By:
- Publication type:
- Article
Néoplasie intra-épithéliale de haut grade du canal anal : tous les chemins ne mènent pas au cancer...
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 7, p. 744, doi. 10.1684/hpg.2020.1995
- By:
- Publication type:
- Article
Marre de vomir, place à l'éléctro !
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 6, p. 636, doi. 10.1684/hpg.2020.1968
- By:
- Publication type:
- Article
Opérer ou ne pas opérer, telle est la question en cas de reflux gastro-œsophagien réfractaire aux inhibiteurs de la pompe à protons.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 2, p. 224, doi. 10.1684/hpg.2019.1923
- By:
- Publication type:
- Article
L'ère des essais en face-à-face a enfin débuté dans les MICI : épisode 1, védolizumab versus adalimumab dans la rectocolite hémorragique.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 1, p. 90, doi. 10.1684/hpg.2019.1893
- By:
- Publication type:
- Article
Éradication systématique de Helicobacter pylori en prévention du cancer gastrique : sommes-nous vraiment à l'ouest ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2019, v. 26, n. 9, p. 993, doi. 10.1684/hpg.2019.1871
- By:
- Publication type:
- Article
La séquence vancomycine-transplantation de microbiote fécal mieux que la fidaxomycine dans l'infection récidivante à Clostridium difficile ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2019, v. 26, n. 7, p. 727, doi. 10.1684/hpg.2019.1798
- By:
- Publication type:
- Article
Préparation colique dans les MICI : quand acceptabilité rime avec efficacité...
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2019, v. 26, n. 5, p. 536, doi. 10.1684/hpg.2019.1779
- By:
- Publication type:
- Article
Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-38628-1
- By:
- Publication type:
- Article
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 7, p. 719, doi. 10.1111/apt.15665
- By:
- Publication type:
- Article
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 5, p. 553, doi. 10.1111/apt.15609
- By:
- Publication type:
- Article
Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 9, p. 924, doi. 10.1111/apt.14944
- By:
- Publication type:
- Article
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 7, p. 713, doi. 10.1111/apt.14926
- By:
- Publication type:
- Article
Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 9, p. 1440, doi. 10.1093/ecco-jcc/jjae059
- By:
- Publication type:
- Article
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 3, p. 424, doi. 10.1093/ecco-jcc/jjad169
- By:
- Publication type:
- Article
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 9, p. 1418, doi. 10.1093/ecco-jcc/jjad060
- By:
- Publication type:
- Article
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysis.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 2, p. 269, doi. 10.1093/ecco-jcc/jjac137
- By:
- Publication type:
- Article
Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective Cohort.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 8, p. 1211, doi. 10.1093/ecco-jcc/jjac026
- By:
- Publication type:
- Article
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 8, p. 1269, doi. 10.1093/ecco-jcc/jjac021
- By:
- Publication type:
- Article
Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 7, p. 1140, doi. 10.1093/ecco-jcc/jjab236
- By:
- Publication type:
- Article
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 5, p. 766, doi. 10.1093/ecco-jcc/jjaa244
- By:
- Publication type:
- Article
Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn's Disease: A Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 2, p. 222, doi. 10.1093/ecco-jcc/jjaa177
- By:
- Publication type:
- Article
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 7, p. 896, doi. 10.1093/ecco-jcc/jjaa005
- By:
- Publication type:
- Article